European Journal of Nutrition

, Volume 50, Issue 5, pp 305–312 | Cite as

Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland

  • Jyrki K. Virtanen
  • Tarja Nurmi
  • Sari Voutilainen
  • Jaakko Mursu
  • Tomi-Pekka Tuomainen
Original Contribution

Abstract

Purpose

To investigate the association between serum 25-hydroxyvitamin D [25(OH)D] concentration, a marker of vitamin D status, and risk of all-cause and cardiovascular mortality in a general older population with relatively low average serum 25(OH)D concentrations.

Methods

The study population included 552 men and 584 women aged 53–73 years who were free of CVD and cancer at baseline in 1998–2001 from the prospective, population-based Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Deaths were ascertained by a computer linkage to the national cause of death register. All deaths that occurred from the study entry to December 31, 2008, were included. Cox proportional hazards regression models were used to analyze the association between serum 25(OH)D and risk of death.

Results

The mean serum 25(OH)D concentration was 43.7 nmol/L (SD 17.8), with a strong seasonal variation. During the average follow-up of 9.1 years, 87 participants died, 35 from cardiovascular disease (CVD). After multivariable-adjustments, the hazard ratios (HR) for all cause death in the tertiles of serum 25(OH)D were 1, 1.68 (95% CI: 0.92, 3.07) and 2.06 (95% CI: 1.12, 3.80), p for trend = 0.02.

Conclusions

Our study supports the accumulating evidence from epidemiological studies that vitamin D deficiency is associated with increased risk of death. Large-scale primary prevention trials with vitamin D supplementation are warranted.

Keywords

25-hydroxyvitamin D Mortality Prospective study Vitamin D 

Notes

Acknowledgments

We wish to thank our staff at the Research Institute of Public Health for helping with subject recruitment and data collection. The research was supported by the Academy of Finland grants #121206 to J.K. Virtanen and #114526 to T. Nurmi. None of the authors have conflict of interest.

References

  1. 1.
    Mithal A, Wahl DA, Bonjour JP et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807–1820CrossRefGoogle Scholar
  2. 2.
    Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S–1086SGoogle Scholar
  3. 3.
    Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF (2008) Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52:1949–1956CrossRefGoogle Scholar
  4. 4.
    Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029CrossRefGoogle Scholar
  5. 5.
    Wolf M, Shah A, Gutierrez O et al (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72:1004–1013CrossRefGoogle Scholar
  6. 6.
    Dobnig H, Pilz S, Scharnagl H et al (2008) Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340–1349CrossRefGoogle Scholar
  7. 7.
    Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637CrossRefGoogle Scholar
  8. 8.
    Pilz S, Dobnig H, Nijpels G et al (2009) Vitamin D and mortality in older men and women. Clin Endocrinol 71:666–672CrossRefGoogle Scholar
  9. 9.
    Kuroda T, Shiraki M, Tanaka S, Ohta H (2009) Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone 44:168–172CrossRefGoogle Scholar
  10. 10.
    Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57:1595–1603CrossRefGoogle Scholar
  11. 11.
    Semba RD, Houston DK, Ferrucci L et al (2009) Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res 29:525–530CrossRefGoogle Scholar
  12. 12.
    Semba RD, Houston DK, Bandinelli S et al (2010) Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 64:203–209CrossRefGoogle Scholar
  13. 13.
    Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R (2010) Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur J Endocrinol 162:935–942CrossRefGoogle Scholar
  14. 14.
    Visser M, Deeg DJ, Puts MT, Seidell JC, Lips P (2006) Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 84:616–622Google Scholar
  15. 15.
    Zittermann A, Schleithoff SS, Frisch S et al (2009) Circulating calcitriol concentrations and total mortality. Clin Chem 55:1163–1170CrossRefGoogle Scholar
  16. 16.
    Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730–1737CrossRefGoogle Scholar
  17. 17.
    Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373–378CrossRefGoogle Scholar
  18. 18.
    Lamberg-Allardt C, Viljakainen H, and a working group (2006) Follow-up study on the vitamin D status in the Finnish population 2002 and 2004. Reports of the Ministry of Social Affairs and Health. Helsinki, FinlandGoogle Scholar
  19. 19.
    Kilkkinen A, Knekt P, Aro A et al (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170:1032–1039CrossRefGoogle Scholar
  20. 20.
    Salonen JT (1988) Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease risk factor study. Ann Clin Res 20:46–50Google Scholar
  21. 21.
    Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803–811Google Scholar
  22. 22.
    Nyyssönen K, Kaikkonen J, Salonen JT (1996) Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma. Scand J Clin Lab Invest 56:681–689CrossRefGoogle Scholar
  23. 23.
    Salonen R, Seppänen K, Rauramaa R, Salonen JT (1988) Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 8:788–792CrossRefGoogle Scholar
  24. 24.
    Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT (1994) Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330:1549–1554CrossRefGoogle Scholar
  25. 25.
    Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT (2001) Low dietary folate intake is associated with an excess incidence of acute coronary events: the Kuopio Ischemic Heart Disease risk factor study. Circulation 103:2674–2680Google Scholar
  26. 26.
    Salonen JT, Seppanen K, Nyyssonen K et al (1995) Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91:645–655Google Scholar
  27. 27.
    Karppi J, Nurmi T, Olmedilla-Alonso B, Granado-Lorencio F, Nyyssonen K (2008) Simultaneous measurement of retinol, alpha-tocopherol and six carotenoids in human plasma by using an isocratic reversed-phase HPLC method. J Chromatogr B Analyt Technol Biomed Life Sci 867:226–232CrossRefGoogle Scholar
  28. 28.
    Turpeinen U, Hohenthal U, Stenman UH (2003) Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 49:1521–1524CrossRefGoogle Scholar
  29. 29.
    Fleck A (1989) Latitude and ischaemic heart disease. Lancet 1:613CrossRefGoogle Scholar
  30. 30.
    Grimes DS, Hindle E, Dyer T (1996) Sunlight, cholesterol and coronary heart disease. QJM 89:579–589Google Scholar
  31. 31.
    Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867–1875CrossRefGoogle Scholar
  32. 32.
    Grant WB (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164:371–377Google Scholar
  33. 33.
    Mizoue T (2004) Ecological study of solar radiation and cancer mortality in Japan. Health Phys 87:532–538CrossRefGoogle Scholar
  34. 34.
    Grandi NC, Breitling LP, Vossen CY et al (2010) Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 159:1044–1051CrossRefGoogle Scholar
  35. 35.
    Cawthon PM, Parimi N, Barrett-Connor E, et al. (2010) Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab. doi: 10.1210/jc.2010-0638
  36. 36.
    Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469CrossRefGoogle Scholar
  37. 37.
    Hsia J, Heiss G, Ren H et al (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115:846–854CrossRefGoogle Scholar
  38. 38.
    Pilz S, Tomaschitz A, Drechsler C, Dekker JM, Marz W (2010) Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 54:1103–1113Google Scholar
  39. 39.
    Forman JP, Giovannucci E, Holmes MD et al (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063–1069CrossRefGoogle Scholar
  40. 40.
    Garland CF, Gorham ED, Mohr SB, Garland FC (2009) Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19:468–483CrossRefGoogle Scholar
  41. 41.
    Laaksi I, Ruohola JP, Tuohimaa P et al (2007) An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86:714–717Google Scholar
  42. 42.
    Cannell JJ, Vieth R, Umhau JC et al (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134:1129–1140CrossRefGoogle Scholar
  43. 43.
    Watson KE, Abrolat ML, Malone LL et al (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760Google Scholar
  44. 44.
    Targher G, Bertolini L, Padovani R et al (2006) Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 65:593–597CrossRefGoogle Scholar
  45. 45.
    Martins D, Wolf M, Pan D et al (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159–1165CrossRefGoogle Scholar
  46. 46.
    Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89–90:387–392CrossRefGoogle Scholar
  47. 47.
    Witham MD, Nadir MA, Struthers AD (2009) Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27:1948–1954CrossRefGoogle Scholar
  48. 48.
    Pittas AG, Chung M, Trikalinos T et al (2010) Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152:307–314Google Scholar
  49. 49.
    Jorde R, Sneve M, Torjesen P, Figenschau Y (2010) No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 267:462–472CrossRefGoogle Scholar
  50. 50.
    Tuohimaa P, Tenkanen L, Ahonen M et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108:104–108CrossRefGoogle Scholar
  51. 51.
    Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28Google Scholar
  52. 52.
    Pilz S, Tomaschitz A, Drechsler C et al (2010) Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 31:1591–1598CrossRefGoogle Scholar
  53. 53.
    Hagstrom E, Hellman P, Larsson TE et al (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765–2771CrossRefGoogle Scholar
  54. 54.
    Doorenbos CR, van den Born J, Navis G, de Borst MH (2009) Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 5:691–700CrossRefGoogle Scholar
  55. 55.
    Virtanen JK, Voutilainen S, Rissanen TH et al (2005) Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 25:228–233Google Scholar
  56. 56.
    Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85:6–18Google Scholar
  57. 57.
    Souberbielle JC, Body JJ, Lappe JM et al (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9:709–715CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Jyrki K. Virtanen
    • 1
  • Tarja Nurmi
    • 1
  • Sari Voutilainen
    • 1
  • Jaakko Mursu
    • 1
    • 2
  • Tomi-Pekka Tuomainen
    • 1
  1. 1.University of Eastern Finland, Kuopio Campus, Institute of Public Health and Clinical NutritionKuopioFinland
  2. 2.Division of Epidemiology and Community Health, School of Public HealthUniversity of MinnesotaMinneapolisUSA

Personalised recommendations